Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$237,207
+$8,901 QoQ
Shares Held
934
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#4,377
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Accent Capital Management, LLC holds $7,805,317 across 7 Drug Manufacturers - General names. JNJ ranks #3 (3.0% of the industry book) .
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,207 | 934 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $228,306 | 934 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $193,291 | 934 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $173,182 | 934 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $142,668 | 934 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $154,894 | 934 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $115,840 | 801 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $254,272 | 1,569 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $229,325 | 1,569 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $248,200 | 1,569 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $245,925 | 1,569 | Shares | Sole | 2024-03-19 | |
| No filing history on record for this holder in this stock. | ||||||